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Tumors 
a b s t r a c t 
Extra-skeletal Ewing’s sarcoma is among the rarest tumors in adults. The primary sites of 
the tumor dictates symptoms and signs, thus early treatments are compromised when more 
common tumors are lined up as differentials by the location. We present a case of a 35-year- 
old pregnant female who developed a renal Ewing sarcoma during pregnancy. A prior simple 
left kidney cyst in an ultrasound with no tumor signs was spotted. A month after her ce- 
sarean section she visited a doctor when she was sent and admitted for surgery with renal 
cell carcinoma as the primary diagnosis to the Firoozgar hospital. Histology confirmed the 
final diagnosis. To this end, she completed the standard chemotherapy for the renal Ewing 
sarcoma with pulmonary metastasis when she was re-evaluated for the general bone pain, 
diagnosed with multiple bone metastases, and ultimately approached her palliative care. 
She expired after 2 months. This study demonstrates: a gently progressive mass; palpable 
in late stages; introduced rise in mean corpuscular volume and lactate dehydrogenase with 
no drop in the hematocrit. In conclusion, any random parenchymal and/or cortical thick- 
ening in primary ultrasound and/or computed tomography demonstrating a cyst—whether 
displaying internal echo or not— with suggested signs should be furtherly evaluated. 
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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Fig.1 – Abdominopelvic CT; there is a huge retroperitoneal, 
heterogeneously enhancing, solid-cystic mass, originating 
from left kidney, measuring 164 × 143 × 108 mm. The 
mass has occupied most of the left upper abdominal cavity, 
crossing the midline and displacing small bowel loops. 
There is no accompanying lymphadenopathy or renal vein 





























Ewing sarcoma families of tumors (ESFT), which are among
the rarest of neoplastic diseases, require more regards in
the eyes of health care providers. Ewing sarcomas comprise:
primary extra-skeletal Ewing tumors as peripheral primitive
neuroectodermal tumors, extraosseous Ewing sarcoma (EES),
and Askin tumors. Since it is almost atypically presented, eas-
ily compromises primary diagnose and management to more
popular sarcomas [1–4] . In this study, for instance, malignan-
cies derived from the kidney—such as renal cell carcinomas
or transitional cell carcinomas. Regarding strong predilection
of these tumors in children, ESFTs implicate 20% of adults in
a total 0.3 per 100,000 incidence rates [5–8] . The short overall
survival, the late offering accompanied by distant metastasis,
and high local recurrence are the seamy side revealed by this
diagnosis [9] . In is noteworthy that the soft tissue subgroup of
extra-axial tumors, arising from neuroectoderm, is the rarest
among them all [10] . The tendency of Ewing’s tumors invading
the bones, mostly in pediatrics, channeled the studies to fun-
damentally focus on this subgroup. Confusing clinical mani-
festations, scarce resources of EES, and histologic recognition
are the main dilemmas for this disease [11 ,12] . Usually the first
symptom of ESFT is pain [4] —which is divulged by plain radio-
graphs in 2 planes, complemented by computed tomography
(CT), and/or magnetic resonance imaging (MRI), which are in-
dicative of a malignant tumor [13–15] . When most of the arti-
cles focused on the treatment outcomes, radiologic findings—
particularly EES in adults—is yet a terra incognita [16–21] . In
this case report, scenario of the patient covers: initial symp-
toms, the obstacles that led to late and unrecognized diagno-
sis, and compiling past medical signs pertinent to former pub-
lished studies. The researcher’s hope here is to discuss and
share congruent imaging data and criteria in hope of never
encountering a same scenario in future. 
Case presentation 
A 35-year-old woman was evaluated for acute rise in blood
pressure 25 days after her C-section childbirth. In her drug his-
tory, she was administered Sildenafil in the last trimester of
her pregnancy and 5 mg folic acid oral route daily because she
had been told to have megaloblastic anemia and pulmonary
hypertension. On physical examinations, a huge mass was
palpated in her left flank as she claimed a dull pain during
pregnancy in that area. She was then referred to Firoozgar hos-
pital (Tehran, Iran) for further evaluation. Initial ultrasound
showed 117 mm length, 21 mm parenchymal thickening of the
left kidney, with a 110 × 117 mm cyst display internal echo
plus thick septum (showing vascularity on color Doppler) in
the upper pole of the kidney. Suggesting hemorrhagic cyst, fur-
ther evaluation had then been advised. 
In light of past medical records, her ultrasound as an out-
patient, approximately 2 years earlier, provided an extra-renal
pelvis in the right kidney. The left kidney had been 105 mm in
length with 14 mm parenchymal thickness. A 30 × 29 mm cyst
on the superior pole containing echogenic component withsepta without calcification was identified, in which CT was
then recommended for Bosniac staging; however, she did not
cooperate. 
With this in mind, abdominopelvic CT indicated a huge
complex left kidney mass, demonstrating internal cystic
structure with 110 × 160 mm estimated size; crossed abdom-
inal midline, compressing intestinal loops. Pelvic veins; par-
ticularly left gonadal, showed distention. After contrast injec-
tion, heterogeneous enhancement in solid part of the mass
was detected. No evidences of adenopathy or vascular inva-
sion shown. A multilocular collection marked the enhancing
septum 9 × 33 mm at anterior abdominal wall by the recent in-
cision line. Offering renal cell carcinoma (RCC) and lipid poor
angiomyolipoma or sarcoma as differential diagnosis, biopsy
under ultrasonography guide was then advised ( Figs. 1 –3 ). 
Moreover, in pulmonary spiral CT a few noncalcified solid
nodules randomly distributed in both lung fields as large as
10 mm diameters at most, in the left upper lobe segments ad-
joining segmental bronchus. Also a few subpleural nodules in
right lung with 9 mm longitude were accounted as the largest
( Fig. 4 ). The whole body bone scan revealed tracer retention
in pelvis of right kidney with big halo sign with very faint ac-
tivity most probability is due to space-occupying lesion in left
kidney is present. 
She underwent radical left nephrectomy for pathologic
studies since admitting diagnosis had been renal cell car-
cinoma. Primary laboratory results are shown in Table 1 .
The patient was then discharged, and follow-up was made
by her pathology report which represented: “a small round
cell tumor growing in thick serpentine pattern and with
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Fig. 2 – The sagittal view of tumor in abdominal CT. The 
upper limit of tumor is at the level of pancreatic body. The 
lower limit of tumor is at the level of midpart of left kidney. 
The tumor mostly grows anteriorly with exophytic pattern. 
The boundary of the tumor is shown with the white arrow. 
CT, computed tomography. 
Fig. 3 – Coronal view of abdominal CT. The upper limit of 
tumor is at the level of pancreatic body. The lower limit of 
tumor is at the level of midpart of left kidney. The tumor 
mostly grows anteriorly with exophytic pattern. The 
boundary of the tumor is shown with the white arrow. CT, 
computed tomography. 
Table 1 – Initial laboratory findings of the patient. 
Blood sugar 90 mg / dL WBC 6500 × 1000/mm ³
Aspartate 
aminotransferase 
31 U/I Hb 13.5 gm/dL 
Alanine 
aminotransferase 
47 U/I HCT 40 % 
Alkaline phosphatase 325 IU/L MCV 97.1 fL 
K 4 mmol/L MCH 32.8 Pgm 
Na 142 mmol/L Platelet 368 × 1000/mm ³
Urea 17 mg/dL Cr 0.9 mg/dL 
Hb, hemoglobin; Cr, creatinine; HCT, hematocrit; MCV, mean cor- 
puscular volume; MCH, mean cell hemoglobin; K, potassium. 
Fig. 4 – The pulmonary spiral CT indicating noncalcified 
solid nodules randomly distributed in both lung fields and 
in the left upper lobe segments adjoining segmental 
bronchus. Also a few subpleural nodules in right lung with 
9 mm longitude were accounted as the largest. CT, 
computed tomography. 
Fig. 5 – Low power microscopic view, indicating sheets of 
monotonous small round cells nuclei with several mitotic; 

















foci of central necrosis. Tumor cells were monotonous, with
round nuclei, fine chromatin, and indistinct cytoplasm. No
other component seen.” Immunohistochemistry (IHC) stain-
ing showed positive reactivity for CD99, but negative for
GATA3, Synapophysin, PAN-CK, WT1, CD56, Myogenin, and
Desmin. TLE-1 was focally positive and KI67 was 30% posi-
tive. After all, the diagnosis was compatible with renal Ewing’s
sarcoma with lung metastasis. Tumor sized 140 × 130 × 100
mm penetrating renal capsule. Perinephric fat and renal si-
nus were invaded by tumor; veins, adrenal gland, and ureter
margin were free though ( Fig. 5 ). 
Coupled with this finding, VAC/IE regimen (Vincristine,
Adriamycin, Cyclophosphamide, Ifosfamide, and Etoposide)
chemotherapy was initiated for the patients, as her trend of
laboratory findings is shown in Table 2 [22] . She took the
regime for 12 courses. Due to her generalized pain, she un-
derwent a whole body scan. The latter showed multiple dif-
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Table 2 – Remarkable laboratory findings before the chemotherapy cycles. 
Before surgery 1st 2nd 3rd 4th 6th 10th 11th 12th 
LDH (U/L) 801 480 796 381 712 687 
Hb (gm/dL) 13.5 11 10.7 10.5 8.7 8.6 7.7 9.3 7.8 
MCV (fL) 97.1 98.8 99.4 96.5 104.9 102.4 105 107.8 107 
Cr (mg/dL) 0.9 1.2 1.1 1 1 1 1 1 
Alk.p (IU/L) 258 388 295 257 305 238 














































































fuse skeletal metastasis when her therapy inclined toward
palliative treatment with opioid analgesics and Zolondronic
4 mg/IV at home with her own consent with no medical mon-
itoring. She was expired 2 months after her palliative care ap-
proach. 
Discussion 
EES is a far rare disease in adults that can hardly cross one’s
mind in the primary differentials. Not only diverse symp-
toms and signs depend on the originating site, but also early
treatments are compromised when more common tumors are
lined up in differential diagnoses. Surgical excision and his-
tologic findings can differentiate these tumors. Luckily, rele-
vant outcomes in primary imaging can help leading to the ac-
curate diagnosis. A case report in 1993 with renal Ewing sar-
coma was diagnosed in pregnancy. Likewise, the scenario is
as follows: firstly drop in hematocrit, secondly retroperitoneal
mass palpated, and then confirmed on the upper pole of the
kidney by ultra sound, which resulted in gastric obstruction,
predominantly cystic, thick walled, and septation was then
thought to be hemorrhage. T1, T2 weighted axial, and coro-
nal MRI revealed a well-circumscribed mass contiguous with
the upper pole of the kidney. Soft tissue excrescences and sep-
tations were also seen within the mass on T2-wighted images
[15] . Shirkhoda showed the initial contrast-enhanced CT dis-
closes a necrotic soft tissue mass in 4 out of 14 patients and
2 with peripheral enhancement. In 3 patients in whom the
mass was homogeneous it did not enhance. Having detected
the size of the mass, he used the CT for evaluation of the pa-
tient’s tumor response to treatments, the integrity of adjacent
bone, the medullary cavity, and the presence or absence of
metastases. He showed evidence of a dramatic initial response
in follow-up CT [23] . To that end, Guimarães et al revealed
the importance of PET/CT (Positron Emission Tomography/CT)
in restaging and re-evaluation of therapeutic response in pa-
tients with Ewing’s tumor. The method lies on its capability to
provide additional physiological data which generates: clini-
cal implication changes in the therapy scheme, surgical ap-
proach, and treatment interruption. Additionally, it is noted
that even though PET has a high specificity for pulmonary le-
sions, the disadvantage is that a negative study does not rule
out the presence of metastatic nodules when expression of
the glucose transporters and changes in biological behaviors
also reduces the FDG (18F-Fluorodeoxyglucose) uptake by the
lesions between the primary tumor and its pulmonary metas-
tases [24] . Based on the intensity of FDG uptake by the lesions,PET/CT allows for the detection of tumor regression and pro-
gression even before morphologic changes by the anatomic
imaging methods such as CT and MRI [25 ,26] . Barnardt, who
compared 2 cases of ESFT by PET/CT and MRI, however, delin-
eated the impossibility of radiologic tumoral differentiation
among members of the Ewing’s family [27] . 
Yet in the review of other literatures, extraosseous Ewing
tumors unanimously showed similar attenuation to that of
muscle in CT [28] . Low attenuation (lower than the muscles) is
likely corresponding to areas of hemorrhage or necrosis—with
no evident postcontrast enhancement [29] . Hypoechoic and/or
hypodensity heterogeneous soft tissue feature was a common
unspecific correspondence which did not accord with what we
found in CT and ultrasounds [29 ,30] . In the latter study MRI
also showed necrosis and/or cystic enhancement surround-
ing the tumor. 
Although, in older studies [29] , it was thought that any non-
calcified tumor was a hint to Ewing sarcomas, calcification is
seen in 25%-30% of radiological finding in EES according to the
radiologic references. Bone surface with cortical erosion or pe-
riosteal reaction reflects bone involvement in 40% of cases;
however, the retains of medullary cavity (normal fatty marrow
attenuation) disrupts the assumption [28 ,31] . 
In the most recent retrospective review of 100 cases of
pathologically approved ESFT, radiologic features were dis-
cussed. Only 2 were retroperitoneal Ewing sarcoma, both were
having large heterogeneous enhancement on CT abutting the
kidney confined to midline. One of these showed calcification.
Then again, this study had no significant imaging gain in the
EES [32] . 
Conclusion 
All things considered, attained evidences suggest: high mean
corpuscular volume, high lactate dehydrogenase was signif-
icant in the laboratory review of this study with no drop in
hematocrit. Any parenchymal and/or cortical thickening in ul-
trasound and/or CT demonstrating a cyst—whether display-
ing internal echo or not—plus thick septum which sublimes
the diagnosis to hemorrhagic cyst, should be furtherly evalu-
ated. It is also noteworthy that the whole body bone scan can
reveal tracer retention in pelvis. 
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